EUROFINS SCIENT Operating Income 2018-2025 | ERFSF
EUROFINS SCIENT annual/quarterly operating income history and growth rate from 2018 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- EUROFINS SCIENT operating income for the quarter ending June 30, 2025 was $0M, a 0% increase year-over-year.
- EUROFINS SCIENT operating income for the twelve months ending June 30, 2025 was $0M, a 0% increase year-over-year.
- EUROFINS SCIENT annual operating income for 2024 was $0.788B, a 31.34% increase from 2023.
- EUROFINS SCIENT annual operating income for 2023 was $0.6B, a 26.67% decline from 2022.
- EUROFINS SCIENT annual operating income for 2022 was $0.818B, a 45.11% decline from 2021.
|
EUROFINS SCIENT Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $788 |
| 2023 | $600 |
| 2022 | $818 |
| 2021 | $1,491 |
| 2020 | $917 |
| 2019 | $416 |
| 2018 | $422 |
| 2017 | $345 |
| 2016 | $2,762 |
| 2015 | |
|
EUROFINS SCIENT Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | |
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $15.244B | $8.253B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $153.002B | 27.77 |
| HCA Healthcare (HCA) | United States | $114.483B | 17.75 |
| CVS Health (CVS) | United States | $99.460B | 11.44 |
| Elevance Health (ELV) | United States | $75.335B | 11.24 |
| Cencora (COR) | United States | $69.692B | 21.99 |
| Natera (NTRA) | United States | $28.085B | 0.00 |
| DiDi Global (DIDIY) | China | $23.132B | 21.37 |
| Labcorp Holdings (LH) | United States | $22.980B | 17.52 |
| Viatris (VTRS) | United States | $16.793B | 6.26 |
| Medpace Holdings (MEDP) | United States | $15.268B | 37.90 |
| Solventum (SOLV) | United States | $13.550B | 13.15 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| ICON (ICLR) | Ireland | $12.161B | 12.07 |
| CochLear (CHEOY) | Australia | $11.774B | 0.00 |
| Revvity (RVTY) | United States | $11.518B | 20.04 |
| Charles River Laboratories (CRL) | United States | $9.312B | 17.93 |
| Sonic Healthcare (SKHHY) | Australia | $7.878B | 0.00 |
| Avantor (AVTR) | United States | $7.677B | 11.73 |
| BrightSpring Health Services (BTSG) | United States | $7.156B | 42.67 |
| HealthEquity (HQY) | United States | $6.788B | 25.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.207B | 0.00 |
| PACS (PACS) | United States | $6.058B | 36.84 |
| Bausch + Lomb (BLCO) | Canada | $6.022B | 39.53 |
| Sotera Health (SHC) | United States | $5.043B | 24.32 |
| Alignment Healthcare (ALHC) | United States | $4.352B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.012B | 18.80 |
| GeneDx Holdings (WGS) | United States | $2.436B | 42.79 |
| Organon (OGN) | United States | $2.134B | 2.25 |
| Establishment Labs Holdings (ESTA) | United States | $1.999B | 0.00 |
| Progyny (PGNY) | United States | $1.892B | 37.20 |
| Pediatrix Medical (MD) | United States | $1.794B | 10.71 |
| Surgery Partners (SGRY) | United States | $1.754B | 22.60 |
| Ardent Health (ARDT) | United States | $1.280B | 4.18 |
| InnovAge Holding (INNV) | United States | $1.134B | 167.20 |
| CareDx (CDNA) | United States | $1.001B | 16.36 |
| Teladoc Health (TDOC) | United States | $0.889B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.828B | 13.56 |
| Nutex Health (NUTX) | United States | $0.706B | 5.40 |
| Omada Health (OMDA) | United States | $0.675B | 0.00 |
| Embecta (EMBC) | United States | $0.643B | 3.59 |
| Sonida Senior Living (SNDA) | United States | $0.642B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.594B | 0.00 |
| Enhabit (EHAB) | United States | $0.563B | 25.30 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.466B | 8.57 |
| CryoPort (CYRX) | United States | $0.437B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.409B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.352B | 5.67 |
| So-Young (SY) | China | $0.339B | 0.00 |
| Agilon Health (AGL) | United States | $0.269B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.262B | 0.00 |
| Oncology Institute (TOI) | United States | $0.257B | 0.00 |
| Beauty Health (SKIN) | United States | $0.163B | 0.00 |
| LifeMD (LFMD) | United States | $0.151B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.134B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.097B | 0.00 |
| Biodesix (BDSX) | United States | $0.083B | 0.00 |
| DocGo (DCGO) | United States | $0.076B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.070B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Pomdoctor - (POM) | China | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.10 |
| OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |